Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Plos One|January 24, 2013
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencingValentina Svicher, Valeria Cento, Gabriella Rozera, et al.
Journal of Translational Medicine|December 8, 2021
Multi-omics approach to COVID-19: a domain-based literature reviewChiara Montaldo, Francesco Messina, Isabella Abbate, et al.
Diagnostic Microbiology and Infectious Disease|June 18, 2019
Collaborative national multicenter for the identification of conversion factors from copies/mL to international units/mL for the normalization of HCMV DNA loadFrancesca Sidoti, Antonio Piralla, Cristina Costa, et al.
Plos One|January 13, 2016
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingElizabeth P St John, Birgitte B Simen, Gregory S Turenchalk, et al.
Journal of Virological Methods|April 16, 2014
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencingBirgitte B Simen, Michael S Braverman, Isabella Abbate, et al.
Sexually Transmitted Infections|April 21, 2022
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in ItalyGiorgio Bozzi, Lavinia Fabeni, Isabella Abbate, et al.
The New England Journal of Medicine|July 16, 2011
MYO1E mutations and childhood familial focal segmental glomerulosclerosisCaterina Mele, Paraskevas Iatropoulos, Roberta Donadelli, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2024
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21Lavinia Fabeni, Daniele Armenia, Isabella Abbate, et al.
International Journal of Antimicrobial Agents|December 6, 2023
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)Marta Camici, Roberta Gagliardini, Simone Lanini, et al.
American Journal of Obstetrics & Gynecology MFM|July 29, 2023
Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational studyLorenzo Zammarchi, Lina Rachele Tomasoni, Giuseppina Liuzzi, et al.
Pageof 8